PO-0955: Molecular subtypes and local control in 1054 breast cancer patients treated with de-escalated 3DCRT. (November 2020) - Fodor, A.; Mangili, P.; Brombin, C.; Zerbetto, F.; Longobardi, B.; Borroni, F.; Tummineri, R.; Pasetti, M.; Rancoita, P.; Perna, L.; Dell'Oca, I.; Deantoni, C.L.; et al.